- Home
- AIRE vs TLSA Comparison
AIRE vs TLSA Comparison
Compare AIRE & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- TLSA
- Stock Information
- Founded
- AIRE 2021
- TLSA 2013
- Country
- AIRE United States
- TLSA United Kingdom
- Employees
- AIRE N/A
- TLSA N/A
- Industry
- AIRE
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- TLSA Health Care
- Exchange
- AIRE Nasdaq
- TLSA Nasdaq
- Market Cap
- AIRE 86.1M
- TLSA 87.8M
- IPO Year
- AIRE N/A
- TLSA 2000
- Fundamental
- Price
- AIRE $1.18
- TLSA $1.12
- Analyst Decision
- AIRE Strong Buy
- TLSA
- Analyst Count
- AIRE 1
- TLSA 0
- Target Price
- AIRE $3.00
- TLSA N/A
- AVG Volume (30 Days)
- AIRE 137.2K
- TLSA 1.0M
- Earning Date
- AIRE 05-23-2025
- TLSA 05-09-2025
- Dividend Yield
- AIRE N/A
- TLSA N/A
- EPS Growth
- AIRE N/A
- TLSA N/A
- EPS
- AIRE N/A
- TLSA N/A
- Revenue
- AIRE $379,241.00
- TLSA N/A
- Revenue This Year
- AIRE $462.63
- TLSA N/A
- Revenue Next Year
- AIRE $179.55
- TLSA N/A
- P/E Ratio
- AIRE N/A
- TLSA N/A
- Revenue Growth
- AIRE 18.11
- TLSA N/A
- 52 Week Low
- AIRE $0.53
- TLSA $0.41
- 52 Week High
- AIRE $4.49
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- AIRE 37.96
- TLSA 46.08
- Support Level
- AIRE $1.23
- TLSA $0.96
- Resistance Level
- AIRE $1.43
- TLSA $1.30
- Average True Range (ATR)
- AIRE 0.10
- TLSA 0.18
- MACD
- AIRE 0.00
- TLSA -0.06
- Stochastic Oscillator
- AIRE 19.33
- TLSA 23.53
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.